The four colon cancer cell lines without any alteration in the EGFR pathway (i.e., E705, DIFI, MICOL24, CACO-2), as well as the normal mucosa cell line, were treated with cetuximab in order to evaluate the effect of this drug. This evidence concerns the gene EGFR and malignant colon neoplasm.